Diversified Consumer Services
Company Overview of University of Washington
University of Washington is an educational institution that provides undergraduate, graduate, and research programs. It offers courses in business, social sciences, science, law, medicine, and public affairs. The schools of the university include College of Engineering, School of Dentistry, College of Architecture and Urban Planning, School of Pharmacy, School of Public Health and Community Medicine, School of Business, School of Humanities and Sciences, School of Law, School of Nursing, College of Ocean and Fishery Sciences, and School of Medicine. University of Washington was founded in 1861 and is based in Seattle, Washington.
Seattle, WA 98195
Founded in 1861
Key Executives for University of Washington
President, Chief Executive Officer, Chief Investment Officer, Director, Investment Manager, and Research Analyst
Provost and Vice President of Academic Affairs
Dean of College of Architecture and Urban Planning
Compensation as of Fiscal Year 2014.
University of Washington Key Developments
University of Washington Announces Executive Changes
Feb 12 15
University of Washington Provost and Executive Vice President Ana Mari Cauce was named interim president by the Board of Regents at their regular meeting on February 12, 2015. Her appointment will be effective March 2, 2015. She succeeds President Michael K. Young, who is leaving the UW for Texas AandM University. In her role as president, Cauce will continue the work she has been doing as provost and executive vice president.
BioMotiv, University of California San Francisco and University of Washington Announces Formation of Optikira
Feb 2 15
BioMotiv, the University of California San Francisco and University of Washington are announcing the formation of OptiKira, a platform company that will develop small molecule therapeutics that prevent cell death in pathologies caused by misfolded or unfolded proteins. OptiKira is based on intellectual property exclusively licensed from UCSF and University of Washington. The project was initiated at UCSF and the University of Washington by scientific founders Scott Oakes, MD, Associate Professor of Pathology at UCSF, Feroz Papa, MD, PhD, Associate Professor of Medicine at UCSF, Bradley Backes, PhD, Associate Professor of Medicine at UCSF, and Dustin Maly, PhD, Associate Professor in Chemistry at University of Washington. Dr. Oakes and Dr. Papa are members of the first class of Harrington Scholar-Innovators. Extensive research by the Founders has helped define the biological pathway leading to progressive cell death which characterizes diseases such as retinitis pigmentosa, diabetes, and amyotrophic lateral sclerosis (ALS). They have found that the Unfolded Protein Response (UPR), a mechanism by which the cell deals with functionally abnormal proteins, has an important housekeeping role in cell metabolism. However when overloaded, the 'terminal UPR' results in the accumulation of excessive unfolded proteins and cellular death. The team has synthesized inhibitors of IRE1a to prevent the activation of the terminal UPR, while not disrupting the housekeeping role of the enzyme. They have demonstrated that inhibitors of IRE1a, which they have named kinase-inhibiting RNase attenuators (KIRAs), protect cells from degeneration in preclinical models of retinitis pigmentosa and diabetes.
University of Washington Presents at Pacific Rim Summit 2014, Dec-08-2014 02:30 PM
Dec 4 14
University of Washington Presents at Pacific Rim Summit 2014, Dec-08-2014 02:30 PM. Venue: San Diego, California, United States. Speakers: Sharon Lafferty Doty.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|